Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors

被引：78

作者：

Chen, Jianyong

Bai, Longchuan

Bernard, Denzil

Nikolovska-Coleska, Zaneta

Gomez, Cindy

Zhang, Jian

Yi, Han

Wang, Shaomeng ^{[1
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 02期

关键词：

STAT3; inhibitor; SH2; domain; apoptosis; SOLID-PHASE SYNTHESIS; SIGNAL TRANSDUCER; SMALL-MOLECULE; PEPTIDOMIMETIC INHIBITORS; SH2; DOMAIN; DIMERIZATION; ACTIVATOR; TARGETS; BINDING; PHOSPHOPEPTIDES;

D O I：

10.1021/ml100010j

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report herein the structure-based design of a class of conformationally constrained, potent, cell-permeable small-molecule inhibitors to target the SH2 domain in STAT3. Compound 11 (CJ-1383) binds to STAT3 with a K-i value of 0.95 mu M, dose-dependently inhibits cellular STAT3 signaling and cancer cell growth, and induces apoptosis in the MDA-MB-468 cancer cell line with constitutively activated STAT3.

引用

页码：85 / 89

页数：5

共 50 条

[1] Structure-based design of potent, conformationally constrained, cell-permeable STAT3 inhibitors
Chen, Jianyong
Bai, Longchuan
Zhao, Yujun
Bernard, Denzil
Nikolovska-Coleska, Zaneta
Gomez, Cindy
Zhang, Jian
Yi, Han
Wang, Shaomeng
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[2] Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1)
Stachel, SJ
Coburn, CA
Steele, TG
Jones, KG
Loutzenhiser, EF
Gregro, AR
Rajapakse, HA
Lai, MT
Crouthamel, MC
Xu, M
Tugusheva, K
Lineberger, JE
Pietrak, BL
Espeseth, AS
Shi, XP
Chen-Dodson, E
Holloway, MK
Munshi, S
Simon, AJ
Kuo, L
Vacca, JP
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (26) : 6447 - 6450
[3] Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors
Scheidt, KA
Roush, WR
McKerrow, JH
Selzer, PM
Hansell, E
Rosenthal, PJ
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (12) : 2477 - 2494
[4] Structure-based design of potent, conformationally constrained Smac mimetics
Sun, HY
Nikolovska-Coleska, Z
Yang, CY
Xu, L
Liu, ML
Tomita, Y
Pan, HG
Yoshioka, Y
Krajewski, K
Roller, PP
Wang, SM
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (51) : 16686 - 16687
[5] RATIONAL STRUCTURE-BASED DESIGN AND EVALUATION OF NOVEL STAT3 INHIBITORS THAT TARGET MALIGNANT BRAIN TUMORS
Daniels, David J.
Peterson, Tim E.
Dietz, Allan B.
Knutson, Gaylord J.
Parney, Ian F.
NEURO-ONCOLOGY, 2012, 14 : 32 - 33
[6] A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro
Zhao, Wei
Jaganathan, Soumya
Turkson, James
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (46) : 35855 - 35865
[7] Structure-based design of novel conformationally restricted HIV protease inhibitors
Rao, B.G.
Baker, C.T.
Court, J.T.
Deininger, D.D.
Griffith, J.P.
Kim, E.E.
Kim, J.L.
Li, B.
Pazhanisamy, S.
Salituro, F.G.
Schairer, W.C.
Tung, R.D.
ACS Symposium Series, 719 : 185 - 197
[8] Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic
Sun, Haiying
Nikolovska-Coleska, Zaneta
Lu, Jianfeng
Qiu, Su
Yang, Chao-Yie
Gao, Wei
Meagher, Jennifer
Stuckey, Jeanne
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7916 - 7920
[9] Structure-Based Rational Design of Constrained Peptides as TIM-3 Inhibitors
Abdel-Rahman, Somaya A.
Ovchinnikov, Victor
Gabr, Moustafa T.
ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 806 - 813
[10] Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain
McMurray, J. S.
Mandal, P. K.
Liao, W. S.
Ren, Z.
Chen, X.
BIOPOLYMERS, 2007, 88 (04) : 604 - 604

← 1 2 3 4 5 →